Australia markets open in 8 hours 50 minutes

Moleculin Biotech, Inc. (MBRX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.0250+0.0450 (+1.13%)
As of 11:00AM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-26,824
-29,769
-29,025
-15,894
-17,355
Depreciation & amortisation
129
127
130
164
200
Stock-based compensation
1,978
1,984
2,275
2,373
1,680
Change in working capital
171
1,622
224
1,038
-41
Accounts payable
165
403
731
235
-1,024
Other working capital
-24,925
-24,225
-27,706
-18,970
-18,147
Other non-cash items
117
891
92
96
85
Net cash provided by operating activities
-24,801
-24,101
-27,639
-18,951
-17,771
Cash flows from investing activities
Investments in property, plant and equipment
-
-124
-67
-19
-376
Net cash used for investing activities
-
-124
-67
-19
-374
Cash flows from financing activities
Common stock issued
4,025
4,166
0
74,684
22,561
Other financing activities
-
485
-23
-23
-17
Net cash used provided by (used for) financing activities
4,510
4,651
-23
74,724
22,549
Net change in cash
-20,441
-19,595
-27,758
55,730
4,438
Cash at beginning of period
37,265
43,145
70,903
15,173
10,735
Cash at end of period
16,850
23,550
43,145
70,903
15,173
Free cash flow
Operating cash flow
-24,801
-24,101
-27,639
-18,951
-17,771
Capital expenditure
-
-124
-67
-19
-376
Free cash flow
-24,925
-24,225
-27,706
-18,970
-18,147